The ROE as of December 2025 (TTM) for United Therapeutics Corporation (UTHR) is 18.83%

According to United Therapeutics Corporation’s latest financial reports and current stock price. The company's current ROE is 18.83%. This represents a change of 299.30% compared to the average of 4.72% of the last 4 quarters.

United Therapeutics Corporation (UTHR) Historical ROE (quarterly & annually)

How has UTHR ROE performed in the past?

The mean historical ROE of United Therapeutics Corporation over the last ten years is 19.37%. The current 18.83% ROE has changed -2.77% with respect to the historical average. Over the past ten years (40 quarters), UTHR's ROE was at its highest in in the March 2016 quarter at 13.67%. The ROE was at its lowest in in the March 2019 quarter at -21.15%.

United Therapeutics Corporation (UTHR) ROE by Quarter and Year

Discovering the peaks and valleys of United Therapeutics Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

United Therapeutics Corporation (UTHR) Average ROE

How has UTHR ROE performed in the past?

The current ROE of United Therapeutics Corporation (UTHR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

United Therapeutics Corporation (UTHR) ROE vs. Peers

How is UTHR’s ROE compared to its peers?

United Therapeutics Corporation’s ROE is less than Incyte Corporation (29.83%), less than Genmab A/S (24.67%), less than Royalty Pharma plc (15.20%), less than Quest Diagnostics Incorporated (13.75%), less than Zimmer Biomet Holdings, Inc. (6.25%), less than Tenet Healthcare Corporation (33.61%), less than Illumina, Inc. (29.98%), less than West Pharmaceutical Services, Inc. (17.33%), less than Waters Corporation (31.34%), less than Biogen Inc. (9.25%),

Build a custom stock screener for United Therapeutics Corporation (UTHR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like United Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

United Therapeutics Corporation (UTHR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like United Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.